Skip to content

Medical emergency? What to do

Diabetes drug may help obese people eat less

3-RXPublished June 13, 20073 min read

Key points

  • Obese subjects ate nearly 1,000 fewer calories per day when they injected pramlintide, a drug approved for the treatment of insulin-dependent diabetes, before every meal, a new study shows.
  • Pramlintide is a synthetic version of the human hormone amylin, which is secreted by the pancreas along with insulin after meals.
  • Christian Weyer of Amylin and his colleagues randomly assigned 88 obese subjects self-injection with pramlintide or placebo before each meal for 6 weeks.
  • While the pramlintide-placebo calorie intake difference shrank as the patients on the drug lost weight, it remained "robust," the researchers note, which is "noteworthy" given that people typically start feeling hungrier after they lose a significant amount of weight.

Obese subjects ate nearly 1,000 fewer calories per day when they injected pramlintide, a drug approved for the treatment of insulin-dependent diabetes, before every meal, a new study shows.

The subjects were also less likely to binge eat and ate less when faced with "fast-food challenges" of deep-dish pizza, sugary sodas and ice cream.

Pramlintide is a synthetic version of the human hormone amylin, which is secreted by the pancreas along with insulin after meals. Amylin is referred to as a "satiety" hormone, meaning it signals a feeling of fullness to let the body know it is time to stop eating.

San Diego-based Amylin Pharmaceuticals makes pramlintide, which is sold under the trade name Symlin. In previous studies, the company demonstrated that people taking Symlin for 1 year lost 8 percent of their body weight. The current study was designed to evaluate how the drug contributes to weight loss.

Dr. Christian Weyer of Amylin and his colleagues randomly assigned 88 obese subjects self-injection with pramlintide or placebo before each meal for 6 weeks. During the course of the study, participants underwent three "fast-food challenges."

By the third day of the study, the subjects on pramlintide were consuming about 750 fewer calories a day than those on placebo and 990 calories a day less than before they began taking the drug. At day 43, those on pramlintide were eating about 500 fewer calories than those on placebo.

While the pramlintide-placebo calorie intake difference shrank as the patients on the drug lost weight, it remained "robust," the researchers note, which is "noteworthy" given that people typically start feeling hungrier after they lose a significant amount of weight.

The subjects on pramlintide also ate smaller portions and consumed less during the fast food challenges. The pramlintide group ate 385 fewer calories on the challenge at 44 days compared with the initial challenge on day 2, while the corresponding number for the placebo group was 109 fewer calories.

By day 44, the pramlintide group lost an average of 2 percent of their total body weight, compared with an average gain of 0.11 percent for those on placebo.

While peptide hormones like pramlintide have been shown to induce nausea, Weyer and his team point out, they used a low dose in the current study, and study participants taking the drug were not significantly more likely to feel nauseous than those on placebo.

Weyer told Reuters Health that his group is now evaluating a combination of pramlintide and leptin -- another satiety hormone -- or treating obesity. Studies in animals have found the combination produces a stronger effect than either hormone alone. The researcher said results of human studies of the hormone combination are expected this year.

SOURCE: American Journal of Physiology, Endocrinology and Metabolism, July 2007.

The content on this site is for information only and is not a substitute for professional medical advice, diagnosis or treatment. Drug information pages are an archive and may be out of date: always follow your prescriber, your pharmacist and the current product label. In an emergency, call 911.

Filed underDiabetesObesity

Keep reading

Children's Health

Childhood obesity genes identified

An international genome-wide study involving thousands of cases identified at least two new gene variants linked to childhood obesity, a U.S. researcher says. Lead investigator Struan F.A. Grant, associate director…

1 min read

Cancer

Risk for some cancers rises with U.S. obesity rate

The total number of Americans dying from or diagnosed with cancer is falling, but certain cancers linked to obesity and inactivity are on the rise, according to an annual report on the status of cancer in the United…

3 min read

When to get help

Reading is for later. These need care now.

Call 911 or go to an emergency department if you or someone with you has any of these:

  • Chest pain or pressureEspecially with breathlessness, sweating or pain in the arm, jaw or back. It can be a heart attack.
  • Face drooping, arm weakness, slurred speechSigns of a stroke. Note the time they started: treatment works best within hours.
  • Severe trouble breathingIncluding a severe allergic reaction with swelling of the lips, tongue or throat.
  • Thoughts of suicideCall or text 988 (Suicide & Crisis Lifeline, US) any time, day or night.

Outside the US, call your local emergency number.

See a doctor within days

  1. 01A new lump, or a sore that does not healMost lumps are harmless, but anything that grows or lasts more than a few weeks should be checked.
  2. 02Unexplained weight loss or lasting fatigueLosing weight without trying, or tiredness that does not lift, can have many causes worth finding.
  3. 03A new medicine and new symptomsSide effects and interactions are common. Ask your pharmacist or prescriber before you stop anything.

General guidance only. If you are unsure how urgent a symptom is, call your doctor or a nurse advice line.